Femasys Closes $30M Private Placement, Grants Board Seats to Lead Investor Alongside Heavy Warrant Issuance
FEMY is trading near its 52-week low of $2.291 (2.6% above the low) on elevated volume (2.3× avg).
Summary
Femasys closed a $30M private placement, issuing shares and warrants with significant dilution potential. The lead investor secured board seats and protective provisions, while prior lender board rights were terminated.
Key Events · Financing and Capital Events · FEMY
-
$30M Private Placement Closed
Femasys raised approximately $30 million in gross proceeds before expenses by issuing 5,013,559 shares at $3.20 per share and pre-funded warrants for 4,361,440 shares at $3.1999 each.
-
Massive Warrant Overhang
Investors received common warrants for 9,374,999 shares and milestone warrants for 9,374,999 shares, both exercisable at $2.95. If fully exercised, total potential dilution from this deal exceeds 23 million shares, more than tripling the current outstanding share count.
-
Lead Investor Gains Board Control
Nantahala Capital Management secured the right to appoint up to two directors and a board observer, along with protective provisions requiring its consent for major actions like CEO termination, debt incurrence over $2.5M, and business changes.
-
Insider Participation
Five company officers, including the CEO, CFO, COO, CTO, and Chief Clinical Officer, purchased $134,000 in securities on the same terms as outside investors.
Analysis · FEMY · Industrial Applications And Services
Femasys closed a $30 million private placement, issuing 5.0 million shares at $3.20 and warrants for an additional 18.7 million shares at $2.95. A side letter grants lead investor Nantahala Capital two board seats and veto rights over major corporate actions. Five insiders participated with $134,000. The company also terminated board rights previously held by its convertible note lender. While the offering was priced at a premium to the current $2.35 stock price, the warrant overhang and governance concessions underscore the company's urgent need for capital amid a going-concern warning and a stock trading near its 52-week low.
At the time of this filing, FEMY was trading at $2.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $2.29 to $22.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.